Aptose Biosciences Inc.
Aptose Biosciences Inc. (APTO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APTO · as of Jun 9, 2026
Key Statistics
Explore Aptose Biosciences Inc. Data
apto stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 90.9%
Competitors & Peers
apto competitorsAPTO
AFMD
ARAV
BCEL
GMDA
GRTSStock Performance
Full HistoryAbout Aptose Biosciences Inc.
Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs wit…
what is aptose biosciences inc. · apto stock overview · aptose biosciences inc. company profile · who is aptose biosciences inc. ceo · apto NASDAQ · aptose biosciences inc. headquarters · aptose biosciences inc. business segments
About Stock Overview & Key Data
Aptose Biosciences Inc. (APTO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 16, 1992. As of the latest trading session, APTO stock price is $1.71, with a market capitalization of $4.4M. The stock has returned -50.86% over the past 12 months and +0.00% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Aptose Biosciences Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Aptose Biosciences Inc. reported revenue of — and net income of —. For detailed data — including Aptose Biosciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aptose Biosciences Inc. (APTO) stock price is $1.71. The stock is traded on NASDAQ under the ticker symbol APTO. The 52-week range is $1.10 – $43.19.